申请人:——
公开号:US20030229102A1
公开(公告)日:2003-12-11
The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof which is useful for the treatment of conditions associated with glutamate hypofunction, such as psychiatric and neurological disorders
1
本发明涉及一种化合物,其
化学式为(I),或其药用可接受的盐,用于治疗与谷
氨酸功能不足相关的疾病,如精神病和神经系统疾病。